Paul Breillat: Targeting Inflammatory Cell Death Pathways in VEXAS Syndrome
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Excited to share our new publication in Blood on VEXAS syndrome!
In this study, we uncover a pathogenic axis in VEXAS linking UBA1 loss of function and defective ubiquitination to:
- RIPK1-mediated inflammatory cell death
- Impaired antimicrobial signaling
- Defective resolution of inflammation
These findings provide evidence that targeting inflammatory cell death pathways represents a promising therapeutic strategy in VEXAS syndrome.
This work would not have been possible without our extraordinary collaborators David Beck, Samuel Magaziner, Stéphane Camus.
Warm thanks to the Foundation for Medical Research and Fonds IMMUNOV for their invaluable support.
Thanks also to the team at Paris Cardiovascular Research Center – PARCC and to INSERM for providing such a stimulating research environment.
Finally, special thanks to Benjamin Terrier for his mentorship and guidance throughout this project.”
Title: Inflammatory cell death and monocyte dysfunction in VEXAS syndrome
Authors: Paul Breillat, Samuel J Magaziner, Stéphane M. Camus, Léa Dionet, Benjamin De Valence De Minardiere, Pierre Sohier, Amine Majdi, Quentin Delcros, Federica Pallotti, Nadia Rivet, Kevin Chevalier, Margot Poux, Sr., Athena Lam, Pierre-Louis Tharaux, Olivia Lenoir, Abdelrahim Zoued, Olivier Kosmider, David B. Beck, Benjamin Terrier
Read the Full Article on Blood.

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?